[1]
“Trastuzumab-Conjugated Nanoparticles: Design And Synthesis Of Trastuzumab-Conjugated Nanoparticles For Targeted Delivery Of Chemotherapeutic Agents To Her2-Positive Breast Cancer Cells”, VER, vol. 8, no. 12s, pp. 310–315, Nov. 2025, Accessed: Jun. 10, 2026. [Online]. Available: https://verjournal.com/index.php/ver/article/view/957